US Broker Ratings

Novo Nordisk A/S (NVO) Investor Outlook: Unpacking a 36.51% Potential Upside

Novo Nordisk A/S (NVO), a Denmark-based pharmaceutical giant, is a name that resonates with innovation and leadership in the healthcare sector. Operating primarily in the Obesity and Diabetes Care and..

Humana Inc. (HUM) Stock Analysis: Exploring a 17.5% Upside Potential for Investors

Humana Inc. (NYSE: HUM), a powerhouse in the healthcare plans industry, presents an intriguing opportunity for investors, highlighted by a potential upside of 17.5%. As a leading provider of medical..

Henry Schein, Inc. (HSIC): Investor Outlook with a 7.5% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC) is a stalwart in the healthcare sector, operating within the medical distribution industry. Founded in 1932 and based in Melville, New York, the company is..

RadNet, Inc. (RDNT) Stock Analysis: Exploring an Attractive 31.43% Upside Potential in the Healthcare Sector

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, has been capturing investor attention with its robust growth potential and strategic positioning within the diagnostics and research industry...

Exact Sciences Corporation (EXAS) Stock Analysis: Evaluating Growth Prospects Amidst Strong Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Known for its innovative cancer screening and diagnostic test products,..

Tempus AI, Inc. (TEM) Stock Analysis: Strong Revenue Growth and Significant Upside Potential

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector with its innovative offerings and impressive revenue growth. With a market capitalization of $9.52 billion, Tempus AI..

argenx SE (ARGX) Stock Analysis: A Biotech Giant with 33% Upside Potential

argenx SE (NASDAQ: ARGX) has become a notable name in the biotechnology sector, capturing investor attention with its expansive pipeline and robust market presence. Based in the Netherlands, this commercial-stage..

Revvity, Inc. (RVTY) Stock Analysis: Unveiling a 21.62% Potential Upside in the Healthcare Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in Waltham, Massachusetts, Revvity offers a suite of health sciences solutions, technologies,..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 59% Potential Upside in the Booming Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its innovative approach to healthcare technology and substantial growth potential. As a leader in the medical devices industry, iRhythm offers..

Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings and Strategic Expansion Drive Investor Interest

Labcorp Holdings Inc. (NYSE: LH) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company stands out in its field, boasting a significant..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a Promising 79% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a leading player in the healthcare sector, is drawing significant attention from investors due to its robust growth prospects and a remarkable potential upside of..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating Opportunities in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to capture attention with its diverse portfolio in the medical devices industry. Based in the United..

Illumina, Inc. (ILMN) Stock Analysis: Exploring the Upside with a 33% Return on Equity

Illumina, Inc. (NASDAQ: ILMN) continues to be a fascinating player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $20.56 billion, Illumina is..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech Innovator with an 89.92% Potential Upside

Investors have their eyes on Summit Therapeutics Inc. (NASDAQ: SMMT), a dynamic player in the biotechnology sector, as the company continues to make strides in developing groundbreaking therapies. With a..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Contender with 20% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector, offering promising growth prospects for investors keen on healthcare innovations. The Danish-based biopharmaceutical company is renowned for its..

Biogen Inc. (BIIB) Stock Analysis: Evaluating the 7.22% Upside Potential Amidst Market Dynamics

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector specializing in drug manufacturing, currently presents a noteworthy opportunity for investors, with its potential upside pegged at 7.22% based..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unlocking a 21.53% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approaches to drug delivery. With a market..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Robust Analyst Ratings Signal Potential 51.69% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, is drawing significant attention from investors. Specializing in rare neuroendocrine diseases, Rhythm Pharmaceuticals has a market capitalization..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Growth Amidst Challenges

Investors eyeing Centene Corporation (NYSE: CNC) may find themselves intrigued by the company’s substantial market presence in the healthcare sector, yet wary of its current valuation metrics and performance indicators...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds